Status:
RECRUITING
Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur
Lead Sponsor:
Costantino Errani
Conditions:
Bone Metastases
Eligibility:
All Genders
18+ years
Brief Summary
The investigators will collect data of patients treated surgically for impending or pathological fracture of the proximal femur due to bone metastases between 01/01/2000 and 31/12/2023 with IMN or THA...
Eligibility Criteria
Inclusion
- Male and female adult patients surgically treated between 01/01/2000 and 31/12/2023 in Rizzoli Orthopaedic Institute and in Massachusetts General Hospital.
- Age ≥18 y (at the time of surgery)
- Patients with impending or pathological fracture due to bone metastases of the proximal femur (head/neck, intertrochanteric, subtrochanteric area).
- Patients who underwent either IMN or THA or HHA or Mega or MegaTHA.
- Patients with available clinical and imaging data.
Exclusion
- Patients with pathological or impending fracture of proximal femur due to primary bone tumor.
Key Trial Info
Start Date :
May 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06918860
Start Date
May 30 2024
End Date
December 1 2025
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, Italy, 40134